Date & Time
Monday, April 20, 2026, 4:00 PM - 5:00 PM
Name
122 MAT Strategies that Reduce Recidivism and Improve Chronic Health Outcomes*
Description

Patients with opioid use disorder often face difficulty finding a primary care physician with sufficient knowledge and interest in treating their condition. This can occur due to stigma, regulatory burdens, and a lack of understanding about medications for opioid use disorder (MOUD). Presenters will walk through many clinical examples and hypotheticals about buprenorphine, methadone, and naltrexone so that attendees feel prepared to prescribe these medications. Examples of how jails and prisons treat large numbers of patients with opioid use disorder will be reviewed.

Educational Objectives

  • Describe prescribing practices for buprenorphine's multiple forms (tablets, films, long-acting injectables)
  • Explain why a patient may respond better to methadone than buprenorphine
  • Discuss why the Department of Justice interprets the Americans With Disabilities Act to mandate offering MAT treatment to all incarcerated patients

Level: Intermediate